2025-02-12 - Analysis Report
## Eli Lilly and Co (LLY) Stock Report

**0. Key Figures Overview:**

LLY's cumulative return significantly outperforms the S&P 500 (VOO), showing a substantial divergence.  Recent price action indicates a slight downward trend, although it remains above its 20-day and 60-day moving averages.  High RSI and positive PPO suggest overbought conditions.  Earnings show mixed results with fluctuating EPS, and strong, relatively consistent Profit Margins and Revenue.


**1. Performance Comparison:**

Eli Lilly and Co. (LLY) is a pharmaceutical company.

* **LLY Cumulative Return:** 629.46%
* **VOO (S&P 500) Cumulative Return:** 120.25%
* **Return Difference:** 509.21% (This is the difference in cumulative return between LLY and VOO as of the last day in the dataset).
* **Relative Divergence:** 81.0% (This indicates LLY's performance is in the 81st percentile relative to its historical performance against the S&P 500 based on the provided min/max range).  This highlights significant outperformance.

**Alpha and Beta Analysis:**

The provided data shows consistently positive alpha values from 2017 onwards, indicating LLY has consistently outperformed the market. Beta values are generally around 1, suggesting similar volatility to the market, though some periods show less volatility.  Market capitalization (Cap(B)) has grown significantly over the period.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 9.0% | 4.3% | -19.0% | 67.9 |
| 2016-2018  | 47.0% | 4.3% | 29.0% | 0.0 | 95.4 |
| 2017-2019  | 60.0% | 8.7% | 29.0% | 1.1 | 110.8 |
| 2018-2020  | 90.0% | 11.1% | 62.0% | 0.3 | 145.2 |
| 2019-2021  | 145.0% | 11.1% | 74.0% | 0.2 | 241.1 |
| 2020-2022  | 196.0% | 11.1% | 188.0% | 0.2 | 323.7 |
| 2021-2023  | 300.0% | 10.8% | 277.0% | 0.3 | 520.8 |
| 2022-2024  | 396.0% | 11.1% | 363.0% | 0.3 | 694.3 |
| 2023-2025  | 386.0% | 11.1% | 325.0% | 0.3 | 777.9 |


**2. Recent Price Action:**

* **Closing Price:** $865.00
* **5-Day Moving Average:** $864.95
* **20-Day Moving Average:** $801.81
* **60-Day Moving Average:** $788.76
* **Price Change (vs. Previous Close):** -$0.45 (a slight decrease)

The price is above all three moving averages, suggesting a relatively strong short-term trend.


**3. Technical Indicators:**

* **RSI:** 82.38 (Indicates overbought conditions; the stock may be due for a correction).
* **PPO:** 1.09 (Positive and above zero, suggesting upward momentum).
* **20-Day Relative Divergence Change:** +4.8% (Short-term upward trend).
* **Expected Return (vs. S&P 500):** 96.3% (Significant long-term outperformance is expected). The recent price drop is relatively small and doesn't suggest a major shift.

**4. Recent Earnings Analysis:**

The earnings data shows some volatility in EPS.  Note that there is a duplicate entry for 2024-10-30.  Revenue has generally been increasing, though there is some fluctuation. Further investigation is needed to understand the reasons behind the EPS volatility and the duplicate data point.

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-10-30 | 1.08  | $11.44B       |
| 2024-08-08 | 3.29  | $11.30B       |
| 2024-04-30 | 2.49  | $8.77B        |
| 2023-11-02 | -0.06 | $9.50B        |
| 2024-10-30 | -0.06 | $9.50B        |


**5. Financial Information:**

Revenue is relatively consistent and shows a general upward trend. Profit margins are consistently high, hovering around 80%.  ROE shows some variability but is generally high suggesting strong profitability. Further investigation would be beneficial to understand the significant drop in ROE during 2023-09-30.

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $11.44B | 81.02%       |
| 2024-06-30 | $11.30B | 80.80%       |
| 2024-03-31 | $8.77B  | 80.91%       |
| 2023-12-31 | $9.35B  | 80.88%       |
| 2023-09-30 | $9.50B  | 80.42%       |


**Capital and Profitability:**

| Quarter | Equity   | ROE     |
|---------|----------|---------|
| 2024-09-30 | $14.24B | 6.81%   |
| 2024-06-30 | $13.56B | 21.88%  |
| 2024-03-31 | $12.81B | 17.51%  |
| 2023-12-31 | $10.77B | 20.33%  |
| 2023-09-30 | $11.22B | -0.51%  |



**6.  Overall Analysis:**

LLY has shown exceptional performance, significantly outperforming the S&P 500.  While current technical indicators suggest overbought conditions, the strong historical performance, positive alpha, and high profit margins indicate a potentially strong long-term investment opportunity. However, the volatility in EPS and the significant drop in ROE in Q3 2023 require further investigation.  A more in-depth analysis of the underlying drivers of these fluctuations,  along with a review of the duplicate earnings data point, is crucial for a comprehensive assessment.  The high expected return warrants consideration, but potential corrections due to the overbought condition should be factored into any investment strategy.
